Celebrex in treatment of joint diseases in patients with risk factors of gastropathy and cardiovascular palhalodydevelopment

Literature digest is presented concerning to gastrointestinal and cardiovascular safety of selective COX- 2 inhibitors including results of Russian clinico-endoscopic study of celebrex efficacy and tolerability in osteoarthritis (OA). Celebrex was administered to the pts with risk factors of gastroi...

Descrición completa

Detalles Bibliográficos
Main Authors: N. V. Chichasova, G R Imametdinova, E L Nassonov
Formato: Artigo
Idioma:Russian
Publicado: IMA PRESS LLC 2004-02-01
Series:Научно-практическая ревматология
Subjects:
Acceso en liña:https://rsp.mediar-press.net/rsp/article/view/1234